KENT WARREN LEYDE
Pilots at 223 Pl, Redmond, WA

License number
Washington C1012115
Category
Airmen
Address
Address
2036 223Rd Pl NE, Redmond, WA 98074

Professional information

Kent Leyde Photo 1

Systems And Methods For Characterizing A Patient's Propensity For A Neurological Event And For Communicating With A Pharmacological Agent Dispenser

US Patent:
2007014, Jun 28, 2007
Filed:
Dec 28, 2005
Appl. No.:
11/322150
Inventors:
Mike Bland - Seattle WA, US
Kent Leyde - Sammamish WA, US
David Snyder - Bainbridge Island WA, US
Daniel Dilorenzo - Seattle WA, US
International Classification:
A61K 9/22
US Classification:
604890100
Abstract:
The present invention provides systems and methods for managing intake of a pharmacological agent. In one method of the present invention, the systems and methods are for controlling intake of an anti-epileptic drug. In such embodiments, one or more signals from a patient are processed to predict an onset of a seizure. Upon the prediction of the seizure, the patient is allowed to access the pharmacological agent in a pharmacological agent dispenser.


Kent Leyde Photo 2

Method And Apparatus For Securing And/Or Identifying A Link To A Percutaneous Probe

US Patent:
6937892, Aug 30, 2005
Filed:
Sep 27, 2002
Appl. No.:
10/260202
Inventors:
Kent Leyde - Sammamish WA, US
John F. Harris - Bellevue WA, US
Paul C. Leonard - Woodinville WA, US
Bradford Evan Gliner - Sammamish WA, US
Assignee:
Meagan Medical, Inc. - Reno NV
International Classification:
A61N001/00
US Classification:
607 2
Abstract:
A method and apparatus for administering percutaneous electrical therapy to a recipient. The apparatus can include an electrical coupler having a coupling member configured to be removably positioned at least proximate to a percutaneous probe. The coupling member can be coupleable to a source of therapeutic electrical signals via a therapeutic signal transmission link to transmit the therapeutic electrical signals to the recipient. The apparatus can further include a status signal transmission link at least proximate to the therapeutic signal transmission link and coupleable to a status signal emitter. The status signal transmission link can be at least tamper-resistant and/or tamper-evident, and can be configured to transmit a status signal having a first characteristic value when the status signal transmission link is in a first condition and a second characteristic value when the status signal transmission link has been altered from a first condition to a second condition.


Kent Leyde Photo 3

Method For Circuit Fault Detection In Differential Signal Detectors

US Patent:
5632280, May 27, 1997
Filed:
Jul 25, 1996
Appl. No.:
8/685999
Inventors:
Kent W. Leyde - Redmond WA
Thomas D. Lyster - Bothell WA
Daniel J. Powers - Issaquah WA
Assignee:
Heartstream, Inc. - Seattle WA
International Classification:
A61B 504
US Classification:
128696
Abstract:
The present invention is an apparatus and method for detecting differential mode signals in an environment where differential mode signals co-exist, and might be corrupted by, common mode signals. The most basic apparatus of the present invention essentially comprises first and second input leads through which both differential mode and common mode signals are input; a first amplifier block having a gain that is substantially one; and at least an inverting node and a non-inverting node connected to the first and second input leads. The output of the amplifier block is fed back to the input of the non-inverting node of the amplifier block in a manner to increase differential mode impedance while maintaining a low common mode impedance. Various embodiments of the basic presently claimed circuitry provides for additional methods of monitoring the level of common-mode signal introduced to the apparatus and other fault detection functions.


Kent Leyde Photo 4

Housing For An Implantable Medical Device

US Patent:
2009017, Jul 2, 2009
Filed:
Dec 23, 2008
Appl. No.:
12/343386
Inventors:
David Brown - Lynwood WA, US
Christopher Genau - Seattle WA, US
Kent W. Leyde - Sammamish WA, US
Shan Gaw - Seattle WA, US
Jeffrey Stewart - Tacoma WA, US
International Classification:
A61N 1/05, A61N 1/08
US Classification:
607 60, 607116
Abstract:
An implantable medical device having a concave ceramic housing component; a concave metal housing component attached to the ceramic housing component to form a hermetically sealed enclosure; and an electronic trans-housing magnetic flux component disposed within the enclosure. Another aspect of the invention provides an implantable medical device having a ceramic housing component; a metal housing component; a circumferential sealing member attached to a periphery of the ceramic housing component and to a periphery of the metal housing component to form a hermetically sealed enclosure; and an electronic trans-housing magnetic flux component disposed within the enclosure. Still another aspect of the invention provides an implantable medical device with a first metal housing component; a second metal housing component, the second metal housing component forming an opening; a ceramic housing component disposed in the opening, the first metal housing component, the second metal housing component and the ceramic housing component cooperating to form a hermetically sealed enclosure; and an electronic trans-housing magnetic flux component disposed within the enclosure.


Kent Leyde Photo 5

Minimally Invasive System For Selecting Patient-Specific Therapy Parameters

US Patent:
2010012, May 20, 2010
Filed:
Jan 21, 2010
Appl. No.:
12/691650
Inventors:
John F. Harris - Bellevue WA, US
Kent W. Leyde - Sammamish WA, US
Jaideep Mavoori - Bellevue WA, US
International Classification:
A61B 5/0476
US Classification:
600544
Abstract:
The present invention provides systems and methods for ambulatory, long term monitoring of a physiological signal from a patient. At least a portion of the systems of the present invention may be implanted within the patient in a minimally invasive manner. In preferred embodiments, brain activity signals are sampled from the patient and are transmitted to a handheld patient communication device for further processing.


Kent Leyde Photo 6

Defibrillator With Automated Test Load

US Patent:
6266562, Jul 24, 2001
Filed:
Apr 30, 1999
Appl. No.:
9/302558
Inventors:
Kent W. Leyde - Redmond WA
Assignee:
Agilent Technologies, Inc. - Palo Alto CA
International Classification:
A61N 136
US Classification:
607 5
Abstract:
A defibrillator is provided with a test load feature which is automatically inserted into electrode paddle jacks when a defibrillator housing lid is closed, placing the defibrillator controller into a TEST MODE. Closing the lid permits actual firing of a shock pulse through the electrode connector through the test load, opening the lid automatically disconnects the test load and permits insertion of electrode paddles, placing the defibrillator into a PATIENT-READY MODE.


Kent Leyde Photo 7

Multi-Channel Amplifier Techniques

US Patent:
2012025, Oct 11, 2012
Filed:
Apr 6, 2012
Appl. No.:
13/441609
Inventors:
Kent W. Leyde - Sammamish WA, US
Tyler R. Hart - Seattle WA, US
Khaled M. Boulos - Renton WA, US
Jason A. Higgins - Seattle WA, US
International Classification:
H05K 7/00, H03F 3/45, H03F 3/68
US Classification:
36167901, 330124 R, 330 69
Abstract:
Techniques for amplifying a plurality of input voltages to generate a corresponding plurality of output voltages. In an exemplary embodiment, each of the plurality of input voltages is referenced to a common voltage comprising the average of the plurality of input voltages, without the need to reference an independently provided common voltage. In an alternative exemplary embodiment, techniques are provided for automatically measuring the input impedance between any two nodes corresponding to the plurality of input voltages. Further techniques are provided for coupling input nodes of the amplifier modules to a common reference voltage, and to the housing of the apparatus.


Kent Leyde Photo 8

Low Power Device With Variable Scheduling

US Patent:
2008016, Jul 3, 2008
Filed:
Dec 27, 2006
Appl. No.:
11/616793
Inventors:
Kent Leyde - Sammamish WA, US
John Harris - Bellevue WA, US
International Classification:
A61B 5/0476
US Classification:
600544
Abstract:
Medical device systems and methods for operating medical device systems conserve energy by efficiently managing computational demands of the systems. Signals from a subject are processed and analyzed and an estimate of a propensity for a subject to have a neurological event is determined. Based on the results of the analysis and the estimate, further analysis may be performed and the estimate may be refined. Succeeding cycles of signal measurement and analysis are scheduled depending on the results of the analysis and the estimate. The schedule may be varied temporally or with regard to the types and intensities of analyses performed.


Kent Leyde Photo 9

Systems And Methods Of Reducing Artifact In Neurological Stimulation Systems

US Patent:
8295934, Oct 23, 2012
Filed:
Nov 14, 2006
Appl. No.:
11/599179
Inventors:
Kent W. Leyde - Sammamish WA, US
Assignee:
NeuroVista Corporation - Seattle WA
International Classification:
A61N 1/08
US Classification:
607 45, 607 2, 607 44
Abstract:
The present invention relates to neurological systems and methods of use which acquire physiological signals from a subject and stimulate the subject. The system is adapted to control the timing at which the system acquires the physiological signals from the subject and the timing of the stimulation signal to reduce the amount of stimulation induced artifact that is acquired by the system.


Kent Leyde Photo 10

Communication Error Alerting In An Epilepsy Monitoring System

US Patent:
2011021, Sep 1, 2011
Filed:
Mar 23, 2011
Appl. No.:
13/070333
Inventors:
Kent W. Leyde - Sammamish WA, US
John F. Harris - Bellevue WA, US
International Classification:
A61B 5/00, A61B 5/04
US Classification:
600301, 600544
Abstract:
Systems and methods for monitoring neurological signals in a patient are provided. The system includes: an implantable sensor adapted to collect neurological signals; an implantable assembly configured to sample the neurological signals collected by the sensor; and a rechargeable communication device external to the patient's body, said communication device configured to wirelessly communicate with the implantable assembly and to transmit a communication error alert to a caregiver advisory device in the event of a communication error between the implantable assembly and the communication device.